Cite
HARVARD Citation
Davids, M. et al. (n.d.). INITIAL RESULTS OF A MULTICENTER PHASE 2 STUDY OF VENETOCLAX IN COMBINATION WITH DOSE‐ADJUSTED R‐EPOCH FOR PATIENTS WITH RICHTER'S SYNDROME (CRC‐043). Hematological oncology. pp. 134-135. [Online].